Kane Justin M, Costanzo James A, Raikin Steven M
Thomas Jefferson University Hospital, Philadelphia PA, USA.
Rothman Institute, Philadelphia, PA, USA
Foot Ankle Int. 2016 Apr;37(4):373-7. doi: 10.1177/1071100715619681. Epub 2015 Nov 26.
The use of platelet-rich plasma (PRP) to aid in healing of operative incisions has been well documented in the literature. Most studies have been conducted retrospectively with small sample sizes and are conflicting in their outcomes. As such, no consensus exists regarding the utility of PRP for augmenting incisional healing. The Agility total ankle replacement (TAR) poses a significant challenge with respect to incisional healing in the immediate postoperative time frame and was used as a standardized implant in this study. We hypothesized that treating the anterior incision with PRP after Agility TAR would reduce the incidence of incision healing complications.
A retrospective review of 133 consecutive Agility TAR performed by a single surgeon at a single institution was conducted. Platelet-rich plasma was used to augment incisional closure in 78 patients undergoing TAR. Fifty-five patients had incisional closure without PRP application. Incision healing complications were stratified into patients healing without any complications (none), patients requiring prolonged local wound care (minor), and patients requiring a return to the operation theater to address an incisional complication (major).
No statistically significant difference existed between patients treated with PRP incisional augmentation and those without PRP augmentation. Eight patients (10.3%) receiving PRP underwent operative treatment of an incisional complication, whereas 3 patients (5.5%) who had a nonaugmented closure required operative treatment (P = .52). The incidence of minor complications was not statistically significant, with 25 (32.1%) patients receiving PRP and 15 (27.3) patients who had a nonaugmented closure requiring prolonged local treatment (P = .85).
Limited data exist regarding the use of PRP in the augmentation of the closure of operative incisions. We were unable to find a statistically significant reduction in incision-related complications in patients who had their incisions augmented with PRP.
Level III, retrospective comparative study.
文献中已充分记载了使用富血小板血浆(PRP)辅助手术切口愈合的情况。大多数研究为回顾性研究,样本量较小,且结果相互矛盾。因此,关于PRP在促进切口愈合方面的效用尚无共识。敏捷全踝关节置换术(TAR)在术后即刻的切口愈合方面带来了重大挑战,本研究将其用作标准化植入物。我们假设在敏捷TAR术后用PRP处理前侧切口会降低切口愈合并发症的发生率。
对一名外科医生在单一机构连续进行的133例敏捷TAR手术进行回顾性分析。78例行TAR手术的患者使用富血小板血浆加强切口缝合。55例患者的切口缝合未使用PRP。切口愈合并发症分为无任何并发症愈合的患者(无)、需要延长局部伤口护理的患者(轻度)以及需要返回手术室处理切口并发症的患者(重度)。
接受PRP切口加强治疗的患者与未接受PRP加强治疗的患者之间无统计学显著差异。接受PRP治疗的8例患者(10.3%)因切口并发症接受了手术治疗,而未进行加强缝合的3例患者(5.5%)需要手术治疗(P = 0.52)。轻度并发症的发生率无统计学显著差异,接受PRP治疗的25例患者(32.1%)和未进行加强缝合而需要延长局部治疗的15例患者(27.3%)(P = 0.85)。
关于PRP用于加强手术切口缝合的数据有限。我们未能发现使用PRP加强切口的患者在切口相关并发症方面有统计学显著降低。
III级,回顾性比较研究。